Agios Pharmaceuticals (AGIO) Stock Insights

AGIO price $38.12 +0.09 +0.24%

Ticker
AGIO
Price
$38.12
Change
+0.09 +0.24%
Market cap ?
$2.28B
P/E ?
-5.36
Forward P/E ?
28.75
Dividend yield ?
0.00%
Beta ?
0.63
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
54
Value
46
Quality
47
Growth
69

Stocklytics score rationale: value 46, quality 47, growth 69.

Financials

2016201720182019202020212022202320242025
6989200043011000943870001179120000014240000268230003649800054028000

Agios Pharmaceuticals, Inc. is a biopharmaceutical firm dedicated to the research and advancement of new treatments, specifically targeting cellular metabolism and related biological fields. The company's offerings include PYRUKYND (mitapivat), a medication designed to activate both wild-type and various mutated pyruvate kinase (PK) enzymes, used in the management of hemolytic anemias. Additionally, Agios is…

Fair value

AGIO fair value $28.39. Price $38.12. Price is 34% above fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Calculated with a 10-year free-cash-flow discount. Starting free cash flow 5.13M. Growth 20.00%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 8.70% (beta 0.8). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 59.70M. Net debt -48.92M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the median P/E of the company's industry. That median uses listed stocks worth at least $10 billion with a positive P/E of 100 or below, and the industry needs at least eight of them. Otherwise the sector median is used when that group also has at least eight, then the market median of those large companies. The multiple used is the lower of that median and 1.25 times the stock's own 10-year median P/E, then kept between 8 and 30. If the stock has no 10-year median, the peer median is kept between 8 and 30. Fair value is the average of the cash-flow value and the earnings value when both exist. Card and credit companies use the earnings value only, because changes in customer receivables distort free cash flow. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.

Compare AGIO

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-05—-1.25—51.55M
2026-07-30-1.69-1.6544.74M26.40M
2026-04-29-1.69-1.8120.75M13.30M
2026-02-12-1.85-1.9719.97M12.09M
2025-10-30-1.78-1.9312.88M11.70M
2025-07-31-1.93-1.7412.46M10.28M
2025-05-01-1.55-1.808.73M9.99M
2025-02-13-1.74-1.6910.73M9.35M
2024-10-3116.2215.229.00M9.44M
2024-08-01-1.69-1.588.62M9.31M
2024-05-02-1.45-1.648.19M9.75M
2024-02-15-1.72-1.647.10M7.92M
2023-11-02-1.64-1.697.40M7.53M
2023-08-03-1.51-1.606.71M6.46M
2023-05-04-1.47-1.725.61M5.23M
2023-02-230.67-1.594.31M4.54M
2022-11-03-1.49-1.753.52M5.27M
2022-08-04-1.68-1.785.58M2.91M
2022-05-05-1.74-1.85832.00K864.18K
2022-02-24-1.81-1.71412.94M
2021-11-03-1.48-1.61—2.60M
2021-07-29-1.36-1.3937.35M—
2021-04-29-1.31-1.2341.41M43.53M
2021-02-25-1.41-1.4144.05M40.17M
2020-11-05-1.43-1.4034.71M33.49M
2020-07-30-1.31-1.4237.35M39.06M
2020-04-30-0.59-1.7087.10M246.53M
2020-02-13-1.60-1.7835.44M38.10M
2019-10-31-1.81-1.8526.02M25.88M
2019-08-01-1.87-1.7326.22M23.84M
2019-05-02-1.59-1.7430.23M33.27M
2019-02-14-1.58-1.6530.01M31.72M
2018-11-01-1.63-1.6915.20M15.10M
2018-08-02-1.19-1.6240.41M52.64M
2018-05-04-1.63-1.608.76M8.76M
2018-02-14-1.81-1.659.80M8.99M
2017-11-01-1.59-1.7411.36M12.79M
2017-08-08-1.78-1.5211.35M9.94M
2017-05-04-1.56-1.7910.51M11.52M
2017-02-16-1.34-1.5522.65M25.52M

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-10-22Gheuens SarahBuy500$25.0112.51K
2026-10-22Gheuens SarahSell500$37.5218.76K
2026-10-22Gheuens SarahSell500$25.0112.51K
2026-10-21Gheuens SarahBuy1.49K$25.0137.24K
2026-10-21Gheuens SarahSell1.49K$37.5355.88K
2026-10-21Gheuens SarahSell1.49K$25.0137.24K
2026-08-04Gheuens SarahSell30.00K$30.48914.40K
2026-07-08Backstrom Jay T.Sell1.45K——
2026-07-08Backstrom Jay T.Buy1.45K——
2026-07-01Gheuens SarahBuy8.38K——
2026-07-01Gheuens SarahSell4.01K$37.56150.50K
2026-07-01Gheuens SarahSell8.38K——
2026-06-18Ballal Rahul D.Buy2.82K——
2026-06-18Ballal Rahul D.Buy14.95K$34.16510.69K
2026-06-18Ballal Rahul D.Buy2.93K——
2026-06-18Ballal Rahul D.Sell2.82K——
2026-06-18CAPELLO JEFFREY DBuy14.95K$34.16510.69K
2026-06-18CAPELLO JEFFREY DBuy2.82K——
2026-06-18CAPELLO JEFFREY DBuy2.93K——
2026-06-18CAPELLO JEFFREY DSell2.82K——
2026-06-18Foster-Cheek Kaye IBuy14.95K$34.16510.69K
2026-06-18Foster-Cheek Kaye IBuy2.82K——
2026-06-18Foster-Cheek Kaye IBuy2.93K——
2026-06-18Foster-Cheek Kaye ISell2.82K——
2026-06-18FOUSE JACQUALYN ABuy2.82K——
2026-06-18FOUSE JACQUALYN ABuy14.95K$34.16510.69K
2026-06-18FOUSE JACQUALYN ABuy2.93K——
2026-06-18FOUSE JACQUALYN ASell2.82K——
2026-06-18Ho MaykinBuy2.82K——
2026-06-18Ho MaykinBuy14.95K$34.16510.69K
2026-06-18Ho MaykinBuy2.93K——
2026-06-18Ho MaykinSell2.82K——
2026-06-18Owen Adams CatherineBuy14.95K$34.16510.69K
2026-06-18Owen Adams CatherineBuy2.82K——
2026-06-18Owen Adams CatherineBuy2.93K——
2026-06-18Owen Adams CatherineSell2.82K——
2026-06-18Scadden DavidBuy2.82K——
2026-06-18Scadden DavidBuy14.95K$34.16510.69K
2026-06-18Scadden DavidBuy2.93K——
2026-06-18Scadden DavidSell2.82K——
2026-06-18Smith CynthiaBuy2.82K——
2026-06-18Smith CynthiaBuy14.95K$34.16510.69K
2026-06-18Smith CynthiaBuy2.93K——
2026-06-18Smith CynthiaSell2.82K——
2026-06-18Viswanadhan KrishnanSell3.00K——
2026-06-18Viswanadhan KrishnanBuy3.00K——
2026-06-18Goff BrianSell39.00K——
2026-06-18Goff BrianBuy39.00K——
2026-06-18Burns James WilliamSell3.00K——
2026-06-18Burns James WilliamBuy3.00K——
2026-06-18Gheuens SarahSell3.00K——
2026-06-18Gheuens SarahBuy3.00K——
2026-06-18Jones CeciliaSell3.00K——
2026-06-18Jones CeciliaBuy3.00K——
2026-06-18Milanova TsvetaSell3.00K——
2026-06-18Milanova TsvetaBuy3.00K——
2026-06-18Backstrom Jay T.Buy14.95K$34.16510.69K
2026-06-18Backstrom Jay T.Buy2.93K——
2026-06-13Owen Adams CatherineBuy1.98K——
2026-06-13Owen Adams CatherineSell1.98K——
2026-06-13CAPELLO JEFFREY DBuy1.98K——
2026-06-13CAPELLO JEFFREY DSell1.98K——
2026-04-02Burns James WilliamBuy8.50K——
2026-04-02Burns James WilliamSell3.28K$34.71113.85K
2026-04-02Burns James WilliamSell8.50K——
2026-04-02Gheuens SarahBuy8.50K——
2026-04-02Gheuens SarahSell2.94K$34.71102.05K
2026-04-02Gheuens SarahSell8.50K——
2026-04-02Jones CeciliaBuy8.50K——
2026-04-02Jones CeciliaSell3.14K$34.71109.02K
2026-04-02Jones CeciliaSell8.50K——
2026-04-02Milanova TsvetaBuy8.50K——
2026-04-02Milanova TsvetaSell3.26K$34.71113.22K
2026-04-02Milanova TsvetaSell8.50K——
2026-04-02Viswanadhan KrishnanBuy8.10K——
2026-04-02Viswanadhan KrishnanSell2.96K$34.71102.71K
2026-04-02Viswanadhan KrishnanSell8.10K——
2026-04-02Goff BrianBuy13.50K——
2026-04-02Goff BrianBuy25.53K——
2026-04-02Goff BrianSell6.60K$34.71228.95K
2026-04-02Goff BrianSell12.47K$34.71432.90K
2026-04-02Goff BrianSell13.50K——
2026-04-02Goff BrianSell25.53K——
2026-03-05Viswanadhan KrishnanSell8.10K——
2026-03-05Viswanadhan KrishnanBuy8.10K——
2026-03-05Viswanadhan KrishnanSell2.96K$27.8082.26K
2026-03-03Washburn Theodore James Jr.Sell5.27K$28.88152.26K
2026-03-02Goff BrianBuy13.00K——
2026-03-02Goff BrianBuy18.00K——
2026-03-02Goff BrianSell5.92K$28.96171.39K
2026-03-02Goff BrianSell8.27K$28.96239.41K
2026-03-02Goff BrianBuy8.50K——
2026-03-02Goff BrianSell3.87K$28.96112.08K
2026-03-02Goff BrianSell13.00K——
2026-03-02Goff BrianSell18.00K——
2026-03-02Goff BrianSell8.50K——
2026-03-02Burns James WilliamBuy3.92K——
2026-03-02Burns James WilliamSell1.16K$28.9633.68K
2026-03-02Burns James WilliamBuy4.00K——
2026-03-02Burns James WilliamSell1.19K$28.9634.38K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 252, holders +3 vs prior quarter. Ownership 113.20%.

HolderSharesChangeChange %Value
BLACKROCK, INC.6.46M701.04K+12.18%239.58M
FARALLON CAPITAL MANAGEMENT, L.L.C.5.92M233.40K+4.11%219.59M
STATE STREET CORP3.53M168.75K+5.02%131.14M
LYNX1 CAPITAL MANAGEMENT LP3.41M797.37K+30.53%126.51M
D. E. SHAW & CO., INC.3.11M425.84K+15.88%115.30M
VANGUARD PORTFOLIO MANAGEMENT LLC2.90M287.16K+11.00%107.55M
ARMISTICE CAPITAL, LLC2.81M94.00K+3.46%104.28M
VANGUARD CAPITAL MANAGEMENT LLC2.68M49.53K+1.88%99.52M
ARMISTICE CAPITAL, LLC2.40M-316.00K-11.63%89.06M
ERSTE ASSET MANAGEMENT GMBH2.15M-550.00K-20.33%81.97M
NOMURA ASSET MANAGEMENT INTERNATIONAL INC.2.11M616.37K+41.24%78.33M
GEODE CAPITAL MANAGEMENT, LLC1.57M106.36K+7.25%58.43M
SUSQUEHANNA INTERNATIONAL GROUP, LLP1.38M1.28M+1355.62%51.05M
ADAR1 CAPITAL MANAGEMENT, LLC1.29M1.15M+815.64%47.80M
BNP PARIBAS ASSET MANAGEMENT HOLDING S.A.1.28M-300.80K-19.03%47.50M
DIMENSIONAL FUND ADVISORS LP1.25M97.12K+8.43%46.35M
GW&K INVESTMENT MANAGEMENT, LLC1.21M-8.29K-0.68%44.78M
GOLDMAN SACHS GROUP INC1.15M345.16K+42.84%42.71M
UBS GROUP AG985.83K853.29K+643.80%36.58M
MORGAN STANLEY963.26K-4.27K-0.44%35.75M
NUVEEN, LLC873.56K151.21K+20.93%32.42M
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP810.53K560.07K+223.62%30.08M
FORESITE CAPITAL MANAGEMENT VI LLC785.00K260.00K+49.52%29.13M
CITADEL ADVISORS LLC732.69K666.99K+1015.20%27.19M
AQR CAPITAL MANAGEMENT LLC684.34K684.34KNew25.40M

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Agios Pharmaceuticals (AGIO) Stock Insights

AGIO$38.12+0.09 +0.24%

$2.28B

Market Cap

-5.36

P/E

28.75

Forward P/E

54

Score

Price History